LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 161 filers reported holding LEGEND BIOTECH CORP in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,715,742 | -2.7% | 814,586 | 0.0% | 20.16% | +15.4% |
| Q2 2023 | $56,230,872 | -28.4% | 814,586 | -50.0% | 17.46% | -31.7% |
| Q1 2023 | $78,558,722 | +96494.9% | 1,629,173 | 0.0% | 25.55% | +8.0% |
| Q4 2022 | $81,328 | -99.9% | 1,629,173 | 0.0% | 23.66% | +21.0% |
| Q3 2022 | $66,470,000 | -25.8% | 1,629,173 | 0.0% | 19.56% | -14.5% |
| Q2 2022 | $89,605,000 | +51.3% | 1,629,173 | 0.0% | 22.89% | +104.5% |
| Q1 2022 | $59,204,000 | -22.0% | 1,629,173 | 0.0% | 11.19% | +29.5% |
| Q4 2021 | $75,936,000 | -7.8% | 1,629,173 | 0.0% | 8.64% | +19.6% |
| Q3 2021 | $82,371,000 | – | 1,629,173 | – | 7.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 997,714 | $36,257,000 | 13.28% |
| JOHNSON & JOHNSON | 1,629,173 | $59,204,000 | 11.19% |
| Paradigm Biocapital Advisors LP | 831,728 | $30,225,000 | 7.99% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,100,542 | $39,994,000 | 5.54% |
| HHLR ADVISORS, LTD. | 6,936,617 | $252,077,000 | 5.26% |
| Old Well Partners, LLC | 79,700 | $2,896,000 | 1.94% |
| Parkman Healthcare Partners LLC | 120,473 | $4,378,000 | 1.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 4,500 | $5,632,000 | 1.27% |
| AtonRa Partners | 50,928 | $1,851,000 | 1.00% |
| Avidity Partners Management LP | 1,095,000 | $39,792,000 | 0.83% |